This section on the GAVI Alliance's website provides information about the pilot pneumococcal Advance Market Commitment (AMC), which is an innovative funding mechanism. It incentivizes vaccine makers to produce suitable and affordable vaccines for the world's poorest countries. These countries are then able to plan for immunization programs knowing that vaccines will be available rapidly, in the quantities they need, and at affordable prices. The site contains the pneumococcal AMC annual reports; a timeline that traces the history of the pneumococcal AMC from concept to launch; information on how AMCs work; and details about how manufacturers can participate.
Author(s): GAVI Alliance
Visit web page (English)
(Located at www.gavialliance.org)